Imaging, Timing Considerations, and Creating Criteria in the Academic vs Community Setting

In the third part of their discussion, the panel debates the practical challenges and strategies in managing patients undergoing radioligand therapy for advanced prostate cancer. They also discuss imaging interpretation, toxicity management, and the evolving criteria for assessing disease progression and treatment responses.

Watch the next segment of this roundtable: Real-World Evidence Influencing Academic-Setting Decisions About Radioligand Treatment Timing